Z Squared (ZSQR)
Nasdaq Market Open
Z Squared Inc. is a publicly traded digital asset mining company focused on operating cryptocurrency mining infrastructure across multiple locations in North America. The company describes itself as vertically integrated, meaning it seeks to control key parts of the mining process, from site operations and equipment deployment to asset-specific mining strategies.
Its mining footprint includes facilities in Texas, North Carolina, South Carolina, and Iowa. This geographic spread gives the company exposure to different power markets, operating conditions, and infrastructure environments, which are important considerations for mining businesses where electricity cost, equipment uptime, and cooling efficiency can have a material effect on profitability.
Z Squared mines a diversified set of cryptocurrencies rather than limiting its operations to a single network. Its portfolio includes assets such as Dogecoin and Litecoin, both of which use proof-of-work mining models linked to Scrypt-based hardware. The company also references strategies across algorithms including SHA-256, Scrypt, and kHeavyHash, indicating an emphasis on matching mining equipment and operating plans to the economics of individual digital assets.
The company’s hardware fleet includes specialised ASIC miners, including Antminer models such as the L7, L9, and DG1+. ASIC-based mining is capital intensive and highly competitive, requiring ongoing attention to hash rate, network difficulty, energy pricing, and equipment efficiency. As a listed stock with direct exposure to cryptocurrency mining, Z Squared gives investors a way to follow the economics of proof-of-work digital assets through an operating company rather than through direct ownership of tokens.
Last updated
- Market Cap
- 102.06M
- P/E
- —
- P/FCF
- —
- P/S
- 72.18
- Enterprise Value
- 97M
- Sector
- —
- Industry
- —
- Address
- 105 BRADFORD ROAD, SUITE 420, WEXFORD, PA, 15090
No recent news is linked to this listing.
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 102.06M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 97M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 5.94
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 72.18
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -8.28
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 68.6
- EPS
- -1.99
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -72.26%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -62.73%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.01
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.25
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.25
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 2.87
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 54.18K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 16.4
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 113.77K | 862.05K | 237.44K | 200.68K | 62.87K |
| Gross profit | 68.62K | 816.89K | 192.29K | 155.52K | 17.72K |
| Operating income | -3.91M | -1.99M | -2.48M | -4.52M | -4.06M |
| EBITDA | -3.62M | -1.69M | -2.18M | -4.23M | -3.76M |
| Net income | -3.92M | -1.26M | -2.9M | -4.33M | -3.36M |
| Basic EPS | -0.65 | -0.04 | -0.61 | -1.17 | -1.1 |
| Diluted EPS | -0.65 | -0.04 | -0.61 | -1.17 | -1.1 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 19.79M | 16.15M | 14.18M | 12.19M | 13.45M |
| Total liabilities | 2.21M | 2.09M | 3.26M | 5.11M | 5.99M |
| Total equity | 17.58M | 14.07M | 10.92M | 7.08M | 7.46M |
| Cash & equivalents | 5.21M | 5.67M | 4.91M | 2M | 4.27M |
| Current assets | 5.91M | 7.35M | 5.99M | 3.69M | 4.65M |
| Current liabilities | 1.82M | 1.77M | 2.71M | 4.48M | 5.65M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M |
| Investing cash flow | 591.52K | — | — | — | — |
| Financing cash flow | 704.25K | 2.45M | 5.06M | 125.1K | 6.1M |
| Change in cash | -463.11K | 765.82K | 2.91M | -2.27M | 3.74M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K/A — Z Squared Inc. | View Filing | |
| edgar index | 8-K — Z Squared Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Z Squared Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — Z Squared Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — Z Squared Inc. | View Filing | |
| edgar index | 4 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | SCHEDULE 13D — Z Squared Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Z Squared Inc. | View Filing | |
| form 3 | Form 3 — BSG Series CM, LLC | View Filing | |
| edgar index | 8-K — Z Squared Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — BSG Series CM, LLC | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| edgar index | 3 — Z Squared Inc. | View Filing | |
| form 3 | Form 3 — Halabu David Elias | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 25-NSE — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 144 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 424B3 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 424B3 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 424B3 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 10-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 4 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Sheehy Christine Elise | View Filing | |
| form 4 | Form 4 — Sheehy Christine Elise | View Filing | |
| form 4 | Form 4 — Salkind Gene | View Filing | |
| form 4 | Form 4 — Salkind Gene | View Filing | |
| form 4 | Form 4 — Cochran Christopher P. | View Filing | |
| form 4 | Form 4 — Cochran Christopher P. | View Filing | |
| form 4 | Form 4 — DeSilva Tara | View Filing | |
| form 4 | Form 4 — DeSilva Tara | View Filing | |
| form 4 | Form 4 — Yerace Daniel Alexander | View Filing | |
| form 4 | Form 4 — Yerace Daniel Alexander | View Filing | |
| form 4 | Form 4 — Mehalick David | View Filing | |
| form 4 | Form 4 — Mehalick David | View Filing | |
| form 4 | Form 4 — Calise Chris | View Filing | |
| form 4 | Form 4 — Calise Chris | View Filing | |
| form 4 | Form 4 — Deschamps Philippe | View Filing | |
| form 4 | Form 4 — Deschamps Philippe | View Filing | |
| form 4 | Form 4 — Cogley Brian | View Filing | |
| form 4 | Form 4 — Cogley Brian | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | DEFA14A — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 424B3 — Coeptis Therapeutics Holdings, Inc. | View Filing | |
| edgar index | 8-K — Coeptis Therapeutics Holdings, Inc. | View Filing |